Skip to main content

Table 1 Patient’s characteristics at presentation and after 2 years of tamsulosin monotherapy

From: The relation between baseline PSA and symptomatic progression in Egyptian BPH patients receiving tamsulosin monotherapy: an exploratory multicentric prospective study

ParameterValid NFindings median (range)
At presentation
Age43763 years (50–90)
IPSS43721 (14–30)
Prostate volume43748 g (23–140)
Qmax4379.7 ml/s (5–14.5)
Serum total PSA4371.6 ng/ml (3–3.99)
At 2-year follow-up
IPSS41413 (7–26)
Prostate volume41453 g (26–165)
Qmax41415.6 ml/s (7.5–22)
IPSS change414− 8 (− 20 to 5)
Change of prostate volume4146.1 g (− 28 to 54)
Qmax change4145.55 ml/s (− 4.5 to 16)